We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Clostridioides difficile Contamination Uncovered in Clinical Lab

By LabMedica International staff writers
Posted on 01 Aug 2019
Print article
Image: A photomicrograph of Gram stain of toxigenic Clostridioides difficile from a stool sample (Photo courtesy of the University of Washington).
Image: A photomicrograph of Gram stain of toxigenic Clostridioides difficile from a stool sample (Photo courtesy of the University of Washington).
Clostridioides (formerly Clostridium) difficile infection is one of the most common hospital-acquired (nosocomial) infections and is an increasingly frequent cause of morbidity and mortality among older adult hospitalized patients. C. difficile is a spore-forming, Gram-positive anaerobic bacillus that produces two exotoxins: toxin A and toxin B.

C. difficile colonizes the human intestinal tract after the normal gut flora has been disrupted (frequently in association with antibiotic therapy) and is the causative organism of antibiotic-associated diarrhea and pseudomembranous colitis. C. difficile infection has traditionally considered to be transmitted predominantly within healthcare settings. C. difficile is not recognized as a pathogen that presents a risk of laboratory acquisition.

A team of scientists collaborating with the staff at the Hospital General Universitario Gregorio Marañón (Madrid, Spain) screened laboratory surfaces for C. difficile. Samples were taken in areas that handle C. difficile isolates (high-exposure areas), areas adjacent to high-exposure HE areas or those processing fecal samples (medium exposure areas), and areas that do not process fecal samples or C. difficile isolates (low exposure areas). They also examined C. difficile carriage (hands/rectal samples) of laboratory workers.

The team collected a total of 140 environmental samples from two high-exposure areas (n = 56), two medium exposure areas (n=56), and two low exposure areas (n = 28). Overall, 37.8% (37/98) of surfaces were contaminated with C. difficile, and 17.3% (17/98) with toxigenic C. difficile. High-exposure areas were significantly more contaminated with toxigenic C. difficile than low exposure areas (38.1% [16/42] versus 0.0% [0/14]) and medium exposure areas (38.1% [16/42] versus 2.4% [1/42]). Hands were colonized with toxigenic C. difficile in 11.8% (4/34) of cases. They found no rectal carriage of C. difficile.

The authors concluded that they had found a significant proportion of laboratory surfaces to be contaminated with toxigenic C. difficile, as well as hand colonization of laboratory personnel. They recommend specific control measures for high-risk areas and laboratory personnel working in these areas. The study was published on July 5, 2019, in the journal Clinical Microbiology and Infection.

Related Links:
Hospital General Universitario Gregorio Marañón

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Ultrasound-based duplex sonography combined with a new genetic testing procedure can identify clonal haematopoiesis (Photo courtesy of 123RF)

New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk

A key interest area in cardiovascular research today is the impact of clonal hematopoiesis on cardiovascular diseases. Clonal hematopoiesis results from mutations in hematopoietic stem cells and may lead... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more